Clinical Trials

Phase 2 Active not recruiting

Carcinoid Tumor, Serotonin Syndrome

NCT05361668 2025-10-31

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

36 enrolled 19 charts

Phase NA Active not recruiting

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT05064514 2025-05-01

TRICAR

15 enrolled

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

4 enrolled 7 charts

Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Phase 2 Withdrawn

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

10 enrolled

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT04776876 2021-09-29

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Phase 2 Withdrawn

Serotonin Syndrome

NCT04073017 2021-05-21

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Phase NA Terminated

11 enrolled

Neuroendocrine Tumors, Serotonin Syndrome

NCT04039516 2020-08-04

CHARRT

Phase 2 Unknown

20 enrolled

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT00092287 2020-04-30

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Phase 3 Terminated

4 enrolled

Malignant Carcinoid Syndrome, Serotonin Syndrome

NCT04065165 2020-02-05

TELEFIRST

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

10 enrolled

Neuroendocrine Tumors, Serotonin Syndrome

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

12 enrolled 18 charts

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Carcinoid Tumor, Serotonin Syndrome

NCT00088595 2012-06-04

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

45 enrolled 10 charts